Therapeutic Solutions International, Inc., Appoints Juergen Winkler, MD, ABIHM to Scientific Advisory Board
July 09 2018 - 9:00AM
InvestorsHub NewsWire
Therapeutic Solutions International, Inc.,
Appoints Juergen Winkler, MD,
ABIHM to Scientific Advisory
Board
Pioneer of Functional Medicine Teams Up with Clinical Stage
Biotechnology Company in Commercialization of Non-Toxic
Immunotherapy
Oceanside, CA
-- July
9, 2018
--
InvestorsHub NewsWire -- Therapeutics
Solutions International, Inc., (OTC
Markets:
TSOI) announced today
that Juergen
Winkler, M.D.,
has been
appointed to the Company's
Scientific Advisory
Board.
Dr. Winkler
is
presently practicing at Quantum Functional Medicine in Carlsbad,
CA, which he founded in
2012.
Dr.
Winkler has been a featured
speaker for: the NSCC Women's Health Seminar, Annual IPT/IPTLD
Integrative Cancer Care Conference (Multiple years), Health Freedom
Expo 2011 & 2012, the Japanese Society of Oxidative Medicine in
Osaka Japan, ACOSPM 2010 & 2011 conferences, NSCC Health and
Wellness Series 2013, and various other events. He is the
physician author of
Chapter 5 in "Defeat
Cancer", a
book
describing leading
physicians on the forefront of the battle with Cancer.
"We are really excited
to have Dr. Winkler join our team, working collaboratively with him
in the background he has helped us to refine our latest product
NanoStilbene, a nanoparticle
formulation of pterostilbene, clinically shown to
more
effectively increase blood levels of the molecule as compared to
conventional powder
formulations",
said
Timothy Dixon, President and CEO. "Dr. Winkler brings
vast clinical experience in Functional
Medicine, a way of looking at
the root cause of a person's disease
and
viewing
each person as a unique individual to give
his patients the best
possible outcome in
their
care. Today
we
welcome Dr. Winkler aboard
our
distinguished Scientific Team," added
Mr.
Dixon.
"The Team at
Therapeutic Solutions International represents a highly synergistic
group comprised
of
internationally renowned oncologists, immunologists, and business
people dedicated to finding solutions for cancer in an unbiased
and open-minded
manner"
said
Dr.
Winkler,
adding "Having interacted
with various Team members for over 2 years, I am highly
enthusiastic about contributing to this deeply
motivated
group in their efforts to solve the problem of cancer."
"The Functional
Medicine perspective that Dr. Winkler brings to our group provides
a fresh and highly innovative take on the oncological problems we
deal with. Treatments such as intravenous vitamin C, which Dr.
Winkler has been practicing for over a decade, and are only
now being understood at a molecular level1.
We hope to leverage Dr. Winkler's experiences and
insights
in order to develop novel and non-toxic cancer
immunotherapies." said Dr.
James
Veltmeyer, Chief Medical Officer of the Company.
About Therapeutic Solutions International,
Inc.
Therapeutic Solutions
International is focused on immune modulation for the treatment of
several specific diseases. Immune modulation refers to the ability
to upregulate (make more active) or downregulate (make less active)
one's immune system. The Company's corporate website is
www.therapeuticsolutionsint.com.
1
Lv et al.
Vitamin C preferentially kills cancer stem cells in
hepatocellular carcinoma via SVCT-2.
NPJ Precis Oncol.
2018 Jan 8;2(1):1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871898/
Safe Harbor
Statement
This release contains
forward-looking statements that are based upon current expectations
or beliefs, as well as a number of assumptions about future events.
Although we believe that the expectations reflected in the
forward-looking statements and the assumptions upon which they are
based are reasonable, we can give no assurance that such
expectations and assumptions will prove to have been correct.
Forward-looking statements are generally identifiable by the use of
words like "may," "will," "should," "could," "expect,"
"anticipate," "estimate," "believe," "intend," or "project" or the
negative of these words or other variations on these words or
comparable terminology. The reader is cautioned not to put undue
reliance on these forward-looking statements, as these statements
are subject to numerous risk factors as set forth in our SEC
filings. To the extent that statements in this press release are
not strictly historical, including statements as to product launch
timing, revenue projections, business strategy, outlook,
objectives, future milestones, plans, intentions, goals, future
collaboration agreements, or otherwise as to future events, such
statements are forward-looking, and are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. The forward-looking statements contained in this release
are subject to certain risks and uncertainties that could cause
actual results to differ materially from the statements
made.
CONTACT
INFORMATION
Therapeutic Solutions (PK) (USOTC:TSOI)
Historical Stock Chart
From May 2024 to Jun 2024
Therapeutic Solutions (PK) (USOTC:TSOI)
Historical Stock Chart
From Jun 2023 to Jun 2024